Blood graft composition after plerixafor injection in patients with NHL.
about
Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utilityNew insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies.Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.Optimizing autologous cell grafts to improve stem cell gene therapy.Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.T-cell subsets in autologous and allogeneic peripheral blood stem cell concentrates.Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.Plerixafor: what we still have to learn.Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers.Influence of plerixafor on the mobilization of CD34+ cell subpopulations and lymphocyte subtypes.Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
P2860
Q27012881-0E13BF4D-9828-4555-B822-6036AEF9888EQ34114055-A9EF628A-40B2-4E18-9FDA-8B5FC0594279Q38199707-D8B2522D-5256-4A25-BF2D-3F5238FB4CA7Q38256923-16CC02A0-2739-4558-9665-BDEF6452B296Q38349208-84060C19-9735-4449-9B3E-CB588190214AQ38815488-9F2FE717-C99E-4F0C-BF2E-820994246865Q38880504-85D500AF-6B6B-4A13-BA61-AD5113D7E976Q38886275-5964309F-8FF4-4001-BCF0-84972E1A816AQ39958361-C693E568-1E80-4FCD-97D4-33451002B97AQ40111616-73E9AEE7-9872-472E-A51B-089FAF78D373Q40871937-83168635-3A4C-4836-9344-BFDAC9B3DD85Q40896003-1A2D2225-6B19-4468-BA5C-844910D43820Q43524297-43739261-D8A0-4BB0-AA08-6F3B936DBDF7Q47696715-C1E4C8B8-4A72-4C12-A950-B44AE8FBD069Q48747463-CFA46276-7616-4CE0-9BF2-284B2782D138Q49077951-BF417A6C-1B03-454A-9419-F62C235B95CEQ49433149-2C23B51D-41BC-49D8-B64F-FAE0811A869DQ50959656-429D0C57-74F0-4EE3-A405-1EED4157BE27Q51099240-4319CE31-DECD-4B6B-9B05-F6BC2C4BD5D8
P2860
Blood graft composition after plerixafor injection in patients with NHL.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Blood graft composition after plerixafor injection in patients with NHL.
@en
Blood graft composition after plerixafor injection in patients with NHL.
@nl
type
label
Blood graft composition after plerixafor injection in patients with NHL.
@en
Blood graft composition after plerixafor injection in patients with NHL.
@nl
prefLabel
Blood graft composition after plerixafor injection in patients with NHL.
@en
Blood graft composition after plerixafor injection in patients with NHL.
@nl
P2093
P2860
P1476
Blood graft composition after plerixafor injection in patients with NHL
@en
P2093
Esa Jantunen
Pentti Mäntymaa
Piia Valonen
Tapio Nousiainen
Taru Kuittinen
P2860
P304
P356
10.1111/J.1600-0609.2012.01794.X
P577
2012-05-24T00:00:00Z